Suppr超能文献

弥漫性大 B 细胞淋巴瘤免疫球蛋白基因重排的分子特征:抗原驱动起源和 IGHV4-34 作为非生发中心 B 细胞亚型的一个特定亚群。

Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype.

机构信息

Department of Hematology, University Hospital of Salamanca, Spain.

出版信息

Am J Pathol. 2012 Nov;181(5):1879-88. doi: 10.1016/j.ajpath.2012.07.028. Epub 2012 Sep 11.

Abstract

The pathogenesis of diffuse large B-cell lymphoma (DLBCL) remains partially unknown. The analysis of the B-cell receptor of the malignant cells could contribute to a better understanding of the DLBCL biology. We studied the molecular features of the immunoglobulin heavy chain (IGH) rearrangements in 165 patients diagnosed with DLBCL not otherwise specified. Clonal IGH rearrangements were amplified according to the BIOMED-2 protocol and PCR products were sequenced directly. We also analyzed the criteria for stereotyped patterns in all complete IGHV-IGHD-IGHJ (V-D-J) sequences. Complete V-D-J rearrangements were identified in 130 of 165 patients. Most cases (89%) were highly mutated, but 12 sequences were truly unmutated or minimally mutated. Three genes, IGHV4-34, IGHV3-23, and IGHV4-39, accounted for one third of the whole cohort, including an overrepresentation of IGHV4-34 (15.5% overall). Interestingly, all IGHV4-34 rearrangements and all unmutated sequences belonged to the nongerminal center B-cell-like (non-GCB) subtype. Overall, we found three cases following the current criteria for stereotyped heavy chain VH CDR3 sequences, two of them belonging to subsets previously described in CLL. IGHV gene repertoire is remarkably biased, implying an antigen-driven origin in DLBCL. The particular features in the sequence of the immunoglobulins suggest the existence of particular subgroups within the non-GCB subtype.

摘要

弥漫性大 B 细胞淋巴瘤 (DLBCL) 的发病机制尚不完全清楚。对恶性细胞 B 细胞受体的分析有助于更好地了解 DLBCL 生物学。我们研究了 165 例未特指的 DLBCL 患者的免疫球蛋白重链 (IGH) 重排的分子特征。根据 BIOMED-2 方案扩增克隆性 IGH 重排,并直接对 PCR 产物进行测序。我们还分析了所有完整 IGHV-IGHD-IGHJ (V-D-J) 序列中规则模式的标准。在 165 例患者中,有 130 例确定了完整的 V-D-J 重排。大多数病例(89%)高度突变,但有 12 个序列是真正未突变或轻度突变。三个基因,IGHV4-34、IGHV3-23 和 IGHV4-39,占整个队列的三分之一,其中 IGHV4-34 过度表达(总体占 15.5%)。有趣的是,所有 IGHV4-34 重排和所有未突变序列均属于非生发中心 B 细胞样(非-GCB)亚型。总的来说,我们发现了 3 例符合当前规则重链 VH CDR3 序列标准的病例,其中 2 例属于 CLL 中先前描述的亚组。IGHV 基因库明显偏向,提示 DLBCL 存在抗原驱动的起源。免疫球蛋白序列的特殊特征表明非-GCB 亚型内存在特定的亚组。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验